More than a half-century after top universities began admitting women to their MBA programs, business schools are finally catching up to law and medical schools in gender parity.
Talk of synergies and consolidation may warm the hearts of investors, who are eager for Midland, Michigan-based Dow Chemical to boost returns, but they cast uncertainty over some of central Indiana’s best scientific jobs.
Melody Birmingham-Byrd, president of Duke Energy Indiana, said her role requires an equal focus on the present and future. “We can’t always determine tomorrow’s weather,” she said. “But we do have to plan for the future.”
City leaders want to make the 60-acre tract of land just north of the Indiana University School of Medicine campus a mix of all of the best the city has to offer and catch the eyes of more creative and highly sought-after workers.
Rochelle Herman-Walrond, who said she spent five years secretly recording conversations with former Subway pitchman Jared Fogle, gave copies of the recordings to the Dr. Phil Show, which plans to air them Thursday and Friday.
A Census Bureau survey suggests that medical device firms created 20,000 fewer jobs from 2011 to 2013 than they should have—and some of those missing jobs probably can be blamed on Obamacare’s medical device tax.
Dow Chemical is exploring all options for its subsidiary, Indianapolis-based Dow AgroSciences. The company employs 1,500 workers in the Indianapolis area and, as a stand-alone firm, would be the fifth-largest by revenue in Indiana.
Indiana Horse Racing Commission Chairman Thomas Weatherwax is promising to turn the tide on the industry, even as horse racing struggles across the country.
Eli Lilly shares plunged nearly 10 percent Monday morning after it said it would stop development of evacetrapib, an experimental cholesterol drug with blockbuster potential.
John Lechleiter, CEO of Eli Lilly and Co., said the company remained confident about its drug pipeline even after it weathered a string of failed clinical trials.
A company spokeswoman would not divulge the nature of the complaint but said it included "nothing that implied anything about sexual behavior or criminal activity."
Four of the 10 metro areas that will see the biggest decrease in competition from the Anthem-Cigna merger are in Indiana, according to an analysis by the American Medical Association—with Indianapolis facing the second-biggest impact among all of Anthem’s markets nationwide.
For two years, Eli Lilly and Co. has been building a team of immuno-oncology researchers in New York City and has struck a series of deals with other drug companies.
Calibrium LLC and MB2 LLC, both based in Carmel, have agreed to be sold for undisclosed amounts. They were developing diabetes drugs discovered by the research team of Richard DiMarchi, a chemistry professor at Indiana University.
A woman says former Subway pitchman Jared Fogle told her years ago about his interest in having sex with minors and that she went to authorities who told her to record the conversations.
Sigstr sells software that manages corporate email signatures and the marketing campaigns beneath them. The firm hopes to capitalize on some of the billions of annual corporate email impressions.
Innovative thinking can help Indiana maintain its leadership in the life sciences, can boost Indiana’s economy, and can bring even more important medical breakthroughs to market.
